Géraldine Picard Selected Research

anti-Yo autoantibodies

1/2022	Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
1/2018	Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Géraldine Picard Research Topics

Disease

13	Encephalitis (Encephalitis, Rasmussen) 05/2022 - 02/2014
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2022 - 01/2016
6	Neoplasms (Cancer) 01/2022 - 12/2015
5	Autoimmune Diseases of the Nervous System 01/2021 - 01/2016
4	Glioma (Gliomas) 09/2022 - 10/2020
3	Seizures (Absence Seizure) 09/2022 - 01/2016
3	Teratoma (Teratoid Tumor) 01/2021 - 12/2015
3	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2017 - 12/2015
2	Ataxia (Dyssynergia) 01/2021 - 07/2017
2	Thymoma (Thymic Carcinoma) 10/2020 - 01/2016
2	Isaacs Syndrome (Neuromyotonia) 10/2020 - 01/2016
2	Cerebellar Ataxia (Dysmetria) 10/2020 - 07/2017
2	Nervous System Paraneoplastic Syndromes 01/2020 - 11/2019
2	Tertiary Lymphoid Structures 11/2019 - 01/2018
1	Atrophy 09/2022
1	Epilepsy (Aura) 09/2022
1	Drug Resistant Epilepsy 09/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Paraneoplastic Cerebellar Degeneration 01/2022
1	Paralysis (Palsy) 01/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Myasthenia Gravis 10/2020
1	Temporal Lobe Epilepsy 07/2020
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Mesothelioma 11/2019
1	Mental Disorders (Mental Disorder) 05/2018
1	Cognitive Dysfunction 05/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Dysarthria (Spastic Dysarthria) 07/2017
1	Muscle Rigidity 10/2016
1	Neurologic Manifestations (Neurological Manifestations) 10/2016
1	Rhabdomyolysis 10/2016
1	Coma (Comas) 10/2016
1	Mutism (Selective Mutism) 10/2016
1	Ovarian Teratoma 12/2015

Drug/Important Bio-Agent (IBA)

14	AntibodiesIBA 01/2021 - 02/2014
9	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 02/2014
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
4	Leucine (L-Leucine)FDA Link 09/2022 - 10/2020
3	AutoantibodiesIBA 05/2022 - 01/2016
2	anti-Yo autoantibodiesIBA 01/2022 - 01/2018
2	AntigensIBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2020 - 07/2020
2	Immunoglobulin A (IgA)IBA 11/2019 - 12/2015
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2015
2	N-Methylaspartate (NMDA)IBA 05/2018 - 08/2015
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 09/2022
1	Pharmaceutical PreparationsIBA 09/2022
1	AD 20 (AD-20)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	HLA-DRB1*07 antigenIBA 01/2021
1	Netrin-1IBA 10/2020
1	IpilimumabIBA 11/2019
1	NivolumabIBA 11/2019
1	pembrolizumabIBA 11/2019
1	AutoantigensIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 10/2016
1	Biological ProductsIBA 10/2016

Therapy/Procedure

1	Aftercare (After-Treatment) 11/2019
1	Immunotherapy 01/2017
1	Critical Care (Surgical Intensive Care) 01/2017